NCT03073642

Brief Summary

Fibromyalgia (FM) is a prevalent and disabling disease, that affects mostly women and its main characteristic is chronic pain. Several studies have shown that hydrotherapy is effective in the improvement of symptoms and quality of life of this population; other studies have shown that Pain Therapeutic Education (PTE) is also effective in this sense. PTE is one cheap, easy to apply intervention, with very positive results in chronic pain situations. However, there is a lack of studies that have shown the effects of this intervention on FM. Hence, this study will aim to verify the effectiveness of the hydrotherapy and PTE on women with FM. Sixty women will be randomly allocated in two groups: hydrotherapy and hydrotherapy + PTE. Before treatment start, the investigators will evaluate pain (visual analogue scale, presence of myofascial trigger points and pressure pain threshold over the scalene, upper trapezius, infraspinatus, piriformis, iliopsoas and soleus, bilaterally), quality of life (Fibromyalgia Impact Questionnaire and medical outcomes study 36-item short-form health survey), depression (Beck Depression Inventory), anxiety (Beck Anxiety Inventory) and sleep quality (Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale). Hydrotherapy treatment will last 12 weeks. Women will be evaluated other 3 times: after 6 and 12 weeks (treatment middle and end) and 12 weeks after treatment completion (follow-up). Women in the hydrotherapy group will receive a folder with explanations on FM. Women in the hydrotherapy + PTE will participate of 4 meetings over 12 treatment weeks, in which themes like pain physiology, pain chronification and exacerbation and pain self-management, as well as information on FM will be approached. Statistical analysis will include qualitative and quantitative variable description. Correlation among variables will also be analyzed. Level of significance will be set at 5%.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2017

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 8, 2017

Completed
2.1 years until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2020

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2020

Completed
Last Updated

November 4, 2020

Status Verified

November 1, 2020

Enrollment Period

1.6 years

First QC Date

February 20, 2017

Last Update Submit

November 3, 2020

Conditions

Keywords

HydrotherapyPain education

Outcome Measures

Primary Outcomes (1)

  • Changes in Pain throughout time

    Visual Analogue Scale (VAS - 100mm) for pain

    Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion.

Secondary Outcomes (11)

  • Changes in number of active myofascial trigger points throughout time

    Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion.

  • Changes in depression throughout time

    Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion.

  • Changes in anxiety throughout time

    Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion.

  • Changes in Impact of Fibromyalgia in Quality of life throughout time

    Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion.

  • Changes in Quality of life throughout time

    Before treatment, after 6 and 12 weeks of treatment and after 12 weeks of treatment completion.

  • +6 more secondary outcomes

Study Arms (2)

Hydrotherapy

ACTIVE COMPARATOR

Patients allocated to this group will perform 12 weeks of hydrotherapy treatment, with global exercises. Hydrotherapy sessions will last 45 minutes and will be performed twice a week. Exercises will involve aerobic exercises (in the pool) with exercises for upper and lower limbs, and trunk.

Other: Hydrotherapy

Hydrotherapy and Pain Education

EXPERIMENTAL

Patients allocated to this group will perform 12 weeks of hydrotherapy treatment, with global exercises. Hydrotherapy sessions will last 45 minutes and will be performed twice a week. Exercises will involve aerobic exercises (in the pool) with exercises for upper and lower limbs, and trunk. During the 12 weeks of hydrotherapy treatment, volunteers will also receive 4 sessions of Pain Therapeutic Education, which is also known as Pain Neuroscience Education, which involves patient education on pain neurophysiology, pain chronification and amplification mechanisms, and chronic pain management. These sessions will be performed in specific dates scheduled according to the volunteers' availability, and with intervals that can last from one to two weeks.

Other: Pain EducationOther: Hydrotherapy

Interventions

Together with hydrotherapy, patients will receive pain therapeutic education

Also known as: Pain Neuroscience Education, Pain Therapeutic Education
Hydrotherapy and Pain Education

Hydrotherapy sessions, lasting 45 minutes, twice a week for 12 weeks.

HydrotherapyHydrotherapy and Pain Education

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical and medical Fibromyalgia Diagnosis according to ACR Diagnostic criteria 2010 and 2016;
  • Willing to perform hydrotherapy as treatment.

You may not qualify if:

  • Cognitive deficits that prevent volunteers from understanding evaluation and treatment procedures;
  • Uncontrolled systemic illnesses (diabetes, hypertension);
  • Neurological and musculoskeletal conditions that may interfere in the evaluation and treatment procedures (palsies, sensitivity alterations, advanced osteoarthritis);
  • Infecto-contagious illnesses (especially in the urinary tract);
  • Alcohol or drug abuse;
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of São Carlos

São Carlos, São Paulo, 13565-905, Brazil

Location

Related Publications (3)

  • Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013 Aug;17(8):356. doi: 10.1007/s11916-013-0356-5.

    PMID: 23801009BACKGROUND
  • Ortega E, Bote ME, Giraldo E, Garcia JJ. Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients. Scand J Med Sci Sports. 2012 Feb;22(1):104-12. doi: 10.1111/j.1600-0838.2010.01132.x. Epub 2010 Jun 1.

    PMID: 20536907BACKGROUND
  • Sousa AP, Almeida LA, Lourenco BP, Alvares LD, Avila MA. Pain neuroscience education improves quality of life when added to aquatic exercise therapy for women with fibromyalgia: randomized controlled clinical trial. Disabil Rehabil. 2024 Apr;46(8):1559-1569. doi: 10.1080/09638288.2023.2201510. Epub 2023 Apr 18.

MeSH Terms

Conditions

Fibromyalgia

Interventions

Hydrotherapy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Physical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • Mariana A Avila, Ph.D.

    UFSCar

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
Outcomes assessor will not know in which group volunteers are allocated; Care provider will not know outcome measures for any volunteers before study completion.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double blind randomized controlled trial with 1:1 allocation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 20, 2017

First Posted

March 8, 2017

Study Start

April 1, 2019

Primary Completion

October 31, 2020

Study Completion

November 3, 2020

Last Updated

November 4, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

All results shall be disclosed in a form that no individual volunteers shall be identified.

Locations